Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib-Reference-Cited by-同舟云学术

Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

Published:2020-10-15 Issue:4 Volume:3 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Sci Rep

Author:

Honma Naoko¹,Inoue Takamitsu¹²^ORCID,Tsuchiya Norihiko¹³,Koizumi Atsushi¹,Yamamoto Ryohei¹,Nara Taketoshi¹,Kanda Sohei¹,Huang Mingguo¹,Numakura Kazuyuki¹^ORCID,Saito Mitsuru¹,Narita Shintaro¹²,Satoh Shigeru⁴,Habuchi Tomonori¹²

Affiliation:

1. Department of Urology Akita University Graduate School of Medicine Akita Japan

2. AMED‐CREST Japan Science and Technology Agency Tokyo Japan

3. Department of Urology Yamagata University Faculty of Medicine Yamagata Japan

4. Center for Kidney Disease and Transplantation Akita University Hospital Akita Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.197

Reference32 articles.

1. Epidemiology of renal cell carcinoma in Japan;Tsushima T;Nippon Rinsho,2017

2. Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis

3. Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

4. Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)

5. Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble Fas ligand, soluble Fas receptor, and decoy receptor 3 as disease biomarkers for clinical applications: A review;AIMS Medical Science;2022